RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Sangui BioTech International - Stock

Sangui BioTech International ROCE 2024

Sangui BioTech International ROCE

0.58

Ticker

SGBI

ISIN

US80105B1017

WKN

906757

In 2024, Sangui BioTech International's return on capital employed (ROCE) was 0.58, a -13.75% increase from the 0.68 ROCE in the previous year.

Sangui BioTech International Aktienanalyse

What does Sangui BioTech International do?

Sangui Biotech International Inc. is a biotechnology company based in the USA that focuses on the research and development of medical products. It was founded in 1994 by Dr. Joachim Fleing with the vision of developing a new type of blood substitute that could replace blood transfusions. The company's business model is centered around developing and marketing products that help combat blood diseases and make blood supply safer. They have different divisions focusing on various aspects of medical research and development, including the development of blood substitute products, wound and scar healing products, and products for individuals with stomas. The company also has a line of products for blood clotting. They strive to be a leader in the medical industry and have already achieved success with their innovative products, receiving patents and awards. They collaborate with other companies and research institutions worldwide to develop new products and exchange research findings. Overall, Sangui Biotech International Inc. is an innovative and emerging biotechnology company dedicated to developing medical products to improve people's health and save lives. Sangui BioTech International ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROCE Details

Unraveling Sangui BioTech International's Return on Capital Employed (ROCE)

Sangui BioTech International's Return on Capital Employed (ROCE) is a financial metric that measures the company's profitability and efficiency with respect to the capital employed. It is calculated by dividing earnings before interest and tax (EBIT) by the employed capital. A higher ROCE indicates that the company is effectively utilizing its capital to generate profits.

Year-to-Year Comparison

Analyzing Sangui BioTech International's ROCE annually provides valuable insights into its efficiency in using its capital to generate profits. An increasing ROCE indicates improved profitability and operational efficiency, whereas a decrease might signal potential issues in capital utilization or business operations.

Impact on Investments

Sangui BioTech International's ROCE is a critical factor for investors and analysts for evaluating the company’s efficiency and profitability. A higher ROCE can make the company an attractive investment, as it often signifies that the firm is generating adequate profits from its employed capital.

Interpreting ROCE Fluctuations

Changes in Sangui BioTech International’s ROCE are attributed to variations in EBIT or the capital employed. These fluctuations offer insights into the company’s operational efficiency, financial performance, and strategic financial management, assisting investors in making informed investment decisions.

Frequently Asked Questions about Sangui BioTech International Stock

What is the ROCE (Return on Capital Employed) of Sangui BioTech International this year?

The ROCE of Sangui BioTech International is 0.58 undefined this year.

How has the ROCE (Return on Capital Employed) of Sangui BioTech International developed compared to the previous year?

The ROCE of Sangui BioTech International has increased by -13.75% decreased compared to the previous year.

What does a high ROCE (Return on Capital Employed) mean for investors of Sangui BioTech International?

A high Return on Capital Employed (ROCE) indicates that Sangui BioTech International has efficient capital utilization and is able to achieve a higher return on its invested capital. This can be appealing to investors.

What does a low ROCE (Return on Capital Employed) mean for investors of Sangui BioTech International?

A low ROCE (Return on Capital Employed) can indicate that Sangui BioTech International has an inefficient utilization of its capital and may have difficulty in achieving a satisfactory return on its invested capital. This can be uncertain or unattractive for investors.

How does an increase in ROCE from Sangui BioTech International impact the company?

An increase in the ROCE of Sangui BioTech International can be an indicator of improved company efficiency and show that it is achieving higher profits in relation to its investments.

How does a reduction in the ROCE of Sangui BioTech International affect the company?

A decrease in ROCE of Sangui BioTech International can be an indicator of deteriorated efficiency of the company, indicating that it is generating lower profits in relation to its investments.

What are some factors that can influence the ROCE of Sangui BioTech International?

Some factors that can affect Sangui BioTech International's ROCE include efficiency in managing assets, profitability of investments, cost efficiency, and market conditions.

Why is the ROCE of Sangui BioTech International so important for investors?

The ROCE of Sangui BioTech International is important for investors as it is an indicator of the company's efficiency and shows how successful the company is in relation to its investments. A high ROCE can indicate strong financial performance of the company.

What strategic measures can Sangui BioTech International take to improve the ROCE?

To improve the ROCE, Sangui BioTech International can take measures such as increasing efficiency in asset management, optimizing investments, cost savings, and exploring new revenue sources. It is important for the company to conduct a thorough review of its operations to determine the best strategic actions to improve the ROCE.

How much dividend does Sangui BioTech International pay?

Over the past 12 months, Sangui BioTech International paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Sangui BioTech International is expected to pay a dividend of 0 USD.

What is the dividend yield of Sangui BioTech International?

The current dividend yield of Sangui BioTech International is .

When does Sangui BioTech International pay dividends?

Sangui BioTech International pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Sangui BioTech International?

Sangui BioTech International paid dividends every year for the past 0 years.

What is the dividend of Sangui BioTech International?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Sangui BioTech International located?

Sangui BioTech International is assigned to the 'Health' sector.

Wann musste ich die Aktien von Sangui BioTech International kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Sangui BioTech International from 6/16/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 6/16/2024.

When did Sangui BioTech International pay the last dividend?

The last dividend was paid out on 6/16/2024.

What was the dividend of Sangui BioTech International in the year 2023?

In the year 2023, Sangui BioTech International distributed 0 USD as dividends.

In which currency does Sangui BioTech International pay out the dividend?

The dividends of Sangui BioTech International are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Sangui BioTech International

Our stock analysis for Sangui BioTech International Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Sangui BioTech International Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.